# Antihypertensive Effect of Different Doses of Rostafuroxin in Comparison With Losartan

> **NCT03217825** · PHASE2 · COMPLETED · sponsor: **Windtree Therapeutics** · enrollment: 240 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Rostafuroxin
- **DRUG:** Losartan

## Key facts

- **NCT ID:** NCT03217825
- **Lead sponsor:** Windtree Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2018-02-08
- **Final completion:** 2018-02-08
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2023-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03217825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03217825, "Antihypertensive Effect of Different Doses of Rostafuroxin in Comparison With Losartan". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03217825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*